Stanford scientists dig into the genetics of stomach and esophageal cancers

NCT ID NCT01048281

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study at Stanford University collects tissue and blood samples from 100 adults with or at high inherited risk for stomach, esophageal, or related cancers. Researchers aim to understand how genes and proteins contribute to cancer development. The study does not test any treatment but may point toward future detection or therapy strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could reveal new genetic or protein targets that may lead to better ways to detect or treat upper gastrointestinal cancers in the future.
What could go wrong
This is an observational study, not a treatment trial. It is small (100 participants) and early-stage, so findings may not lead directly to new therapies or apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University School of Medicine

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.